Siga Technologies Inc (SIGA) Stock Price, Quote & News

Company Profile

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 212 672 9100

Website: www.siga.com

Address:

31 East 62nd Street, New York, United States

I_killed_the_kraken Jul. 12 at 8:54 PM

🕵️‍♂️ Could be worth watching $SIGA on Monday. 🧐 Thailand reports 40 monkeypox cases in 2025, urges high-risk groups to practise safe sex. 🔥 Cholera and monkeypox outbreaks kill thousands across Africa. ℹ️ Follow me for more research, it´s free!

1 · Reply

Dostovy Jul. 12 at 8:18 PM

$SIGA https://d18rn0p25nwr6d.cloudfront.net/CIK-0001010086/b4708cc3-5056-4238-b673-62ced4500d20.pdf

0 · Reply

Biotekman Jul. 11 at 2:25 PM

$SIGA Just bought $6000, it could become a growth company in a context of World War III.

0 · Reply

geniuscali Jul. 11 at 1:50 AM

$SIGA any monkey pox in usa yet?

0 · Reply

jlonards Jul. 10 at 3:12 PM

$SIGA trickle trickle

0 · Reply

geniuscali Jul. 9 at 8:56 PM

$SIGA that green and volume at the end. Someone looks like they are accumulating

0 · Reply

Dostovy Jul. 8 at 4:38 PM

$SIGA 🧨

0 · Reply

gsib7 Jul. 8 at 11:39 AM

$SIGA 🚀 headed to 8.00

0 · Reply

geniuscali Jul. 7 at 6:02 PM

$SIGA someone knows somwthing

1 · Reply

Dostovy Jul. 7 at 2:12 PM

$SIGA https://globalbiodefense.com/2025/07/06/mpox-monkeypox-virus-immune-evasion-opg147/

0 · Reply

SIGA Technologies, Inc. (SIGA) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 2 months ago

SIGA Reports Financial Results for Three Months Ended March 31, 2025

May 1, 2025, 7:30 AM EDT - 2 months ago

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

Apr 8, 2025, 7:30 AM EDT - 3 months ago

SIGA Declares Special Cash Dividend of $0.60 Per Share

Apr 7, 2025, 3:02 AM EDT - 3 months ago

SIGA Technologies: Asymmetric Upside, If 2025 Goes Right

Mar 18, 2025, 7:30 AM EDT - 4 months ago

SIGA Appoints Retired General John M. Keane to its Board of Directors

Mar 11, 2025, 8:55 PM EDT - 4 months ago

SIGA Technologies, Inc. (SIGA) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 4:05 PM EDT - 4 months ago

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

Mar 4, 2025, 7:30 AM EST - 4 months ago

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

Jan 2, 2025, 7:30 AM EST - 6 months ago

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Dec 10, 2024, 4:00 PM EST - 7 months ago

Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced

Dec 2, 2024, 5:49 PM EST - 8 months ago

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

EBS

Nov 21, 2024, 5:01 PM EST - 8 months ago

SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket

Nov 8, 2024, 9:18 AM EST - 8 months ago

SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

Nov 7, 2024, 8:55 PM EST - 8 months ago

SIGA Technologies, Inc. (SIGA) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:30 AM EDT - 9 months ago

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

Oct 23, 2024, 8:17 AM EDT - 9 months ago

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

Oct 22, 2024, 7:30 AM EDT - 9 months ago

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

Oct 8, 2024, 7:42 AM EDT - 10 months ago

Siga Technologies to supply mpox therapy in Morocco

Oct 8, 2024, 7:30 AM EDT - 10 months ago

SIGA Announces Agreement to Supply TPOXX® in Morocco

Oct 3, 2024, 12:00 PM EDT - 10 months ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Oct 2, 2024, 3:03 PM EDT - 10 months ago

The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Sep 27, 2024, 8:22 AM EDT - 10 months ago

Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating SIGA Technologies, Inc. for Potential Violations of Federal Securities Laws

Aug 21, 2024, 4:00 PM EDT - 11 months ago

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

Aug 16, 2024, 2:17 PM EDT - 11 months ago

Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study

Aug 16, 2024, 8:00 AM EDT - 11 months ago

SIGA Technologies: Poised For A Potential Windfall From Monkeypox Emergency Declaration

Aug 15, 2024, 8:36 AM EDT - 11 months ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS GOVX

Aug 15, 2024, 7:35 AM EDT - 11 months ago

Topline Results from PALM 007 Study of SIGA's Tecovirimat in Treatment of Mpox Released

Aug 1, 2024, 9:57 PM EDT - 1 year ago

SIGA Technologies, Inc. (SIGA) Q2 2024 Earnings Call Transcript

Jul 25, 2024, 7:30 AM EDT - 1 year ago

SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results

I_killed_the_kraken Jul. 12 at 8:54 PM

1 · Reply

Dostovy Jul. 12 at 8:18 PM

$SIGA https://d18rn0p25nwr6d.cloudfront.net/CIK-0001010086/b4708cc3-5056-4238-b673-62ced4500d20.pdf

0 · Reply

Biotekman Jul. 11 at 2:25 PM

$SIGA Just bought $6000, it could become a growth company in a context of World War III.

0 · Reply

geniuscali Jul. 11 at 1:50 AM

$SIGA any monkey pox in usa yet?

0 · Reply

jlonards Jul. 10 at 3:12 PM

$SIGA trickle trickle

0 · Reply

geniuscali Jul. 9 at 8:56 PM

$SIGA that green and volume at the end. Someone looks like they are accumulating

0 · Reply

Dostovy Jul. 8 at 4:38 PM

$SIGA 🧨

0 · Reply

gsib7 Jul. 8 at 11:39 AM

$SIGA 🚀 headed to 8.00

0 · Reply

geniuscali Jul. 7 at 6:02 PM

$SIGA someone knows somwthing

1 · Reply

Dostovy Jul. 7 at 2:12 PM

$SIGA https://globalbiodefense.com/2025/07/06/mpox-monkeypox-virus-immune-evasion-opg147/

0 · Reply

Lopppendbuffet Jul. 7 at 2:08 PM

$SIGA Im thinking Q2 is gonna be really juicy 🤤

0 · Reply

Jpowll Jul. 3 at 6:23 PM

$SIGA slow and steady

0 · Reply

Dostovy Jul. 3 at 5:22 PM

$SIGA 🫡

0 · Reply

Dostovy Jul. 3 at 11:39 AM

$SIGA As soon as the resistance of $7.12 is broken, the purge of the infected will begin.

0 · Reply

Dostovy Jul. 2 at 7:40 PM

$SIGA Next leg 9.99

0 · Reply

Lopppendbuffet Jul. 2 at 4:36 PM

$SIGA about 30 days till Q2 numbers! will this be the take off for the 2025 bull run 🚀

0 · Reply

ZacksResearch Jul. 2 at 3:07 PM

🔻 $SIGA Falls 6.1% In a Year: Turnaround Ahead? 💊 Delivered $62 million of TPOXX to U.S. stockpile in April = steady gov’t backing 💉 $26 million IV option exercised for 2026 = visibility into future sales 🏭 $14 million new funds secured = stronger IV supply chain resiliency 👀 Eyes on upcoming updates to gauge pipeline depth & global expansion Stronger contenders? Watch these 👇 https://www.zacks.com/stock/research/SIGA/industry-comparison?cid=sm-stocktwits-0-comparison_insdustry-oc&ADID=SYND_STOCKTWITS_TWEET_0_COMPARISONINSDUSTRY_OC

0 · Reply

Dostovy Jun. 30 at 8:43 PM

$SIGA The chart puts us back on the bullish path. We just need news to confirm it.

0 · Reply

petsaregood71 Jun. 30 at 4:22 PM

$SIGA Big, beautiful bill. $$$$

0 · Reply

Dostovy Jun. 30 at 4:06 PM

$SIGA Tecovirimat🪩🕺

0 · Reply

gsib7 Jun. 30 at 3:37 PM

$SIGA 👀 Let’s get this new Contract!!!!!

0 · Reply

geniuscali Jun. 30 at 2:27 PM

$SIGA new contract?

0 · Reply

Market Cap	478.66M
Revenue (ttm)	138.72M
Net Income (ttm)	59.21M
EPS (ttm)	N/A
PE Ratio	10.24
Forward PE	52.77
Profit Margin	42.68%
Debt to Equity Ratio	0.00

Volume	221,300
Avg Vol	416,148
Day's Range	N/A - N/A
Shares Out	71.44M
Stochastic %K	41%
Beta	0.94
Analysts	Strong Buy
Price Target	$11.00